Nezu, Tomohisa
Kitano, Takaya
Kubo, Satoshi
Uemura, Junichi
Yamashita, Shinji
Iwanaga, Takeshi
Inoue, Takeshi
Hosomi, Naohisa
Maruyama, Hirofumi
Matsumoto, Masayasu
Kimura, Kazumi
Yagita, Yoshiki
Funding for this research was provided by:
JSPS KAKENHI (17K17907)
Article History
Received: 11 November 2017
Revised: 5 January 2018
Accepted: 6 January 2018
First Online: 25 January 2018
Compliance with ethical standards
:
: Naohisa Hosomi reports an honorarium from Mochida Pharmaceutical Co., Ltd which is outside the submitted work. Hirofumi Maruyama reports grants from Daiichi Sankyo Co., Ltd which is outside the submitted work. Masayasu Matsumoto reports grants from Takeda Pharmaceutical Co., LTD., Sanofi K.K., Mochida Pharmaceutical Co., LTD., Otsuka Pharmaceutical, and Daiichi Sankyo Co., LTD. and honoraria from Sanofi K.K., Bayer Health Care, and Daiichi Sankyo Co., LTD, which is outside the submitted work. Yoshiki Yagita reports an honorarium from Daiichi Sankyo Co., Ltd which is outside the submitted work. Other authors declare that there is no conflict of interest.
: This study complied with the Declaration of Helsinki for investigations involving humans, and the study protocol was approved by the Ethics Committee of the Kawasaki Medical School Hospital (#2334).